{{Rsnum
|rsid=751837
|Gene=CDC42BPB
|Chromosome=14
|position=103018488
|Orientation=plus
|GMAF=0.1878
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CDC42BPB
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 24.8 | 74.3
| HCB | 0.0 | 5.1 | 94.9
| JPT | 0.0 | 2.7 | 97.3
| YRI | 32.9 | 46.6 | 20.5
| ASW | 26.3 | 40.4 | 33.3
| CHB | 0.0 | 5.1 | 94.9
| CHD | 0.0 | 0.9 | 99.1
| GIH | 0.0 | 5.0 | 95.0
| LWK | 32.7 | 48.2 | 19.1
| MEX | 1.7 | 8.6 | 89.7
| MKK | 11.5 | 56.4 | 32.1
| TSI | 0.0 | 17.6 | 82.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=21471979
|Title=Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility
}}

{{PMID Auto
|PMID=18471798
|Title=Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}